These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Med could reverse arterial blockages. Health News; 2006 Jul; 12(7):13. PubMed ID: 16858860 [No Abstract] [Full Text] [Related]
7. Serum HDL-Cholesterol Level Does Not Influence Cardiovascular Event Rate under Sufficient Lowering of LDL-Cholesterol by Pitavatatin in Patients with Stable Coronary Artery Disease. Masuda D; Yamashita S J Atheroscler Thromb; 2022 Jan; 29(1):8-10. PubMed ID: 33762513 [No Abstract] [Full Text] [Related]
8. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Tani S; Nagao K; Hirayama A Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320 [TBL] [Abstract][Full Text] [Related]
9. Lipid management with statins. The lower the better? Laufs U; Liao JK; Böhm M Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235 [TBL] [Abstract][Full Text] [Related]
10. Candidate mechanisms for regression of coronary atherosclerosis with high-dose statins: insight from intravascular ultrasonography trials. Sipahi I; Tuzcu EM Am J Cardiovasc Drugs; 2008; 8(6):365-71. PubMed ID: 19159123 [TBL] [Abstract][Full Text] [Related]
11. Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins. Ferrières J Am J Cardiovasc Drugs; 2009; 9(2):109-15. PubMed ID: 19331439 [TBL] [Abstract][Full Text] [Related]